SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBP | hg19_v2_chr6_+_170863421_170863484 | -0.56 | 1.0e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_59043166 Show fit | 32.19 |
ENST00000371225.2
|
tumor-associated calcium signal transducer 2 |
|
chr1_+_153330322 Show fit | 31.77 |
ENST00000368738.3
|
S100 calcium binding protein A9 |
|
chr16_+_56659687 Show fit | 21.73 |
ENST00000568293.1
ENST00000330439.6 |
metallothionein 1E |
|
chr11_+_18287801 Show fit | 20.66 |
ENST00000532858.1
ENST00000405158.2 |
serum amyloid A1 |
|
chr13_+_43597269 Show fit | 20.02 |
ENST00000379221.2
|
DnaJ (Hsp40) homolog, subfamily C, member 15 |
|
chr17_-_39780819 Show fit | 19.69 |
ENST00000311208.8
|
keratin 17 |
|
chr11_+_18287721 Show fit | 19.14 |
ENST00000356524.4
|
serum amyloid A1 |
|
chr12_-_52845910 Show fit | 18.22 |
ENST00000252252.3
|
keratin 6B |
|
chr17_-_39780634 Show fit | 18.14 |
ENST00000577817.2
|
keratin 17 |
|
chr14_+_75745477 Show fit | 18.07 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FBJ murine osteosarcoma viral oncogene homolog |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 49.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.7 | 48.8 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
12.1 | 48.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
2.8 | 44.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.0 | 41.2 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
1.2 | 40.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
10.8 | 32.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
3.2 | 32.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.0 | 32.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.8 | 27.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 92.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.9 | 65.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.5 | 51.3 | GO:0035580 | specific granule lumen(GO:0035580) |
1.4 | 47.8 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
1.5 | 39.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.6 | 34.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 32.4 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.1 | 19.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 19.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
2.0 | 18.1 | GO:0035976 | AP1 complex(GO:0035976) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 69.5 | GO:0002020 | protease binding(GO:0002020) |
1.1 | 58.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
6.5 | 51.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.0 | 49.4 | GO:0019841 | retinol binding(GO:0019841) |
12.1 | 48.5 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
6.9 | 48.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
4.2 | 41.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 36.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 27.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 25.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 88.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 73.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 66.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 21.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 18.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 12.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 12.2 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 9.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 9.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 9.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 41.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.2 | 39.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 31.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.7 | 22.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 18.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 16.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 15.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 15.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
1.0 | 15.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 12.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |